A Randomised, Double-blind Placebo-controlled Study to Assess the Safety of Four Single Ascending Doses of HF1020 in Healthy Male Subjects
The study aims to:
* study the safety of the drug (HF1020) in healthy male adults
* study how well the study drug (HF1020) is tolerated in healthy male adults
* find the maximum dose that is tolerated in healthy male adults
100 Clinical Results associated with Trident Pharmaceuticals, Inc.
0 Patents (Medical) associated with Trident Pharmaceuticals, Inc.
100 Deals associated with Trident Pharmaceuticals, Inc.
100 Translational Medicine associated with Trident Pharmaceuticals, Inc.